{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:16:24Z","timestamp":1791411384731,"version":"4.3.3"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.semcancer.2011.09.007","type":"journal-article","created":{"date-parts":[[2011,9,18]],"date-time":"2011-09-18T19:03:32Z","timestamp":1316372612000},"page":"322-334","source":"Crossref","is-referenced-by-count":98,"title":["The complex landscape of genetic alterations in mantle cell lymphoma"],"prefix":"10.1016","volume":"21","author":[{"given":"Cristina","family":"Royo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Salaverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00edas","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Be\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2011.09.007_bib0005","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0010","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07124.x","article-title":"Advances in the understanding of mantle cell lymphoma","volume":"142","author":"Jares","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"Perez-Galan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0035","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants","volume":"93","author":"Bea","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0040","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2008.19.6121","article-title":"Outcome of deferred initial therapy in mantle-cell lymphoma","volume":"27","author":"Martin","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0045","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0050","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0475","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","article-title":"Indolent mantle cell leukemia: clinicopathologic variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis","volume":"96","author":"Ondrejka","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0060","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1200\/JCO.2009.23.9731","article-title":"Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma","volume":"27","author":"Eve","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0065","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood-2007-06-093401","article-title":"Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma","volume":"111","author":"Ek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0070","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/gcc.1216","article-title":"Unusual case of leukemic mantle cell lymphoma with amplified CCND1\/IGH fusion gene","volume":"33","author":"Gruszka-Westwood","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0080","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/gcc.20609","article-title":"Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques","volume":"47","author":"Salaverria","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0085","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/gcc.20187","article-title":"Amplification of IGH\/MYC fusion in clinically aggressive IGH\/BCL2-positive germinal center B-cell lymphomas","volume":"43","author":"Martin-Subero","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0090","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0092-8674(02)00770-5","article-title":"Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations","volume":"109","author":"Zhu","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0095","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/sj.leu.2403459","article-title":"Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma","volume":"18","author":"Wlodarska","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0100","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood.V84.4.1226.1226","article-title":"A variant chromosome translocation at 11q13 identifying PRAD1\/Cyclin D1 as the bcl-1 gene","volume":"84","author":"Komatsu","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gcc.20754","article-title":"Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma","volume":"49","author":"Espinet","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1755-8166-4-8","article-title":"A rare case of t(11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report","volume":"4","author":"Rocha","year":"2011","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0480","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathological study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2006-01-0015","article-title":"A chromosomal translocation in cyclin D1-negative\/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus","volume":"108","author":"Gesk","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cancergencyto.2010.08.016","article-title":"CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus","volume":"204","author":"Shiller","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0130","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2007-10-120824","article-title":"Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression","volume":"111","author":"Herens","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0135","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3324\/haematol.2009.010173","article-title":"Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR","volume":"94","author":"Quintanilla-Martinez","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0140","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1182\/blood-2007-10-118794","article-title":"Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas","volume":"111","author":"Wlodarska","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0145","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1200\/JCO.2006.08.4251","article-title":"Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature","volume":"25","author":"Salaverria","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0150","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-01-263806","article-title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling","volume":"116","author":"Hartmann","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0155","first-page":"346","article-title":"Simultaneous presence of t(11;14) and a variant Burkitt\u2018s translocation in the terminal phase of a mantle cell lymphoma","volume":"10","author":"Tirier","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0160","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.MP.0000037310.82136.99","article-title":"Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features","volume":"15","author":"Hao","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0165","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1365-2141.2001.03056.x","article-title":"Blastic mantle cell lymphoma associated with Burkitt-type translocation and hypodiploidy","volume":"115","author":"Vaishampayan","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0170","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00277-004-0879-2","article-title":"Coexistence of BCL1\/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome","volume":"83","author":"Michaux","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0175","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1080\/10428190701606834","article-title":"Blastoid mantle cell lymphoma with t(2;8) (p12;q24)","volume":"48","author":"Oliveira","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0180","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1200\/JCO.2010.32.8385","article-title":"The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective","volume":"29","author":"Salaverria","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0185","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1080\/10428190600687547","article-title":"Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis","volume":"47","author":"Mossafa","year":"2006","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0190","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/10428190310001593120","article-title":"The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases","volume":"45","author":"Au","year":"2004","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0195","first-page":"1225","article-title":"8q24 translocations in blastic transformation of mantle cell lymphoma","volume":"85","author":"Au","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0200","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/10428190290016890","article-title":"Cytogenetic analysis in mantle cell lymphoma: a review of 214 cases","volume":"43","author":"Au","year":"2002","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0205","first-page":"594","article-title":"Secondary chromosome changes in mantle cell lymphoma","volume":"84","author":"Wlodarska","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0210","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1182\/blood.V89.4.1421","article-title":"Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones","volume":"89","author":"Ott","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0215","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3324\/haematol.13030","article-title":"Secondary genomic alterations in non-Hodgkin's lymphomas: tumor-specific profiles with impact on clinical behavior","volume":"93","author":"Bea","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1098-2264(200003)27:3<285::AID-GCC9>3.0.CO;2-M","article-title":"t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia","volume":"27","author":"Bentz","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0225","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/(SICI)1098-2264(199804)21:4<298::AID-GCC3>3.0.CO;2-U","article-title":"Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma","volume":"21","author":"Monni","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0230","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1182\/blood.V98.12.3479","article-title":"Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma","volume":"98","author":"Martinez-Climent","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0235","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2141.2002.03260.x","article-title":"Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization","volume":"116","author":"Allen","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0240","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1080\/10428190410001683796","article-title":"High incidence of unbalanced chromosomal changes in mantle cell lymphoma detected by comparative genomic hybridization","volume":"45","author":"Jarosova","year":"2004","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0245","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/cncr.22715","article-title":"Leukemic involvement is a common feature in mantle cell lymphoma","volume":"109","author":"Ferrer","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0250","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V99.1.238","article-title":"ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances","volume":"99","author":"Camacho","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0255","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1073\/pnas.0510441103","article-title":"Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma","volume":"103","author":"Greiner","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0260","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2003-12-4175","article-title":"Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions","volume":"104","author":"Kohlhammer","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0265","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2004-10-3907","article-title":"Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome","volume":"105","author":"Rubio-Moscardo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0270","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1073\/pnas.050400997","article-title":"Mantle cell lymphoma is characterized by inactivation of the ATM gene","volume":"97","author":"Schaffner","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0275","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1182\/blood-2004-07-2730","article-title":"Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization","volume":"105","author":"Schraders","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0280","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","article-title":"Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM","volume":"24","author":"Tagawa","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0285","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.leukres.2006.10.022","article-title":"Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma","volume":"31","author":"Flordal","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0290","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2005.05883.x","article-title":"Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma","volume":"132","author":"Rinaldi","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0295","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2141.2008.07443.x","article-title":"GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma","volume":"144","author":"Vater","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0300","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1182\/blood-2008-07-170183","article-title":"Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling","volume":"113","author":"Bea","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0305","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.exphem.2009.04.012","article-title":"Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array","volume":"37","author":"Kawamata","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0310","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/gcc.20836","article-title":"High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival","volume":"50","author":"Halldorsdottir","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0315","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1182\/blood-2006-11-057208","article-title":"Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis","volume":"109","author":"Pinyol","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0320","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0325","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1158\/0008-5472.CAN-09-1095","article-title":"MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas","volume":"69","author":"Navarro","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0330","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)80201-9","article-title":"Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons","volume":"89","author":"Coquelle","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0335","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nature08645","article-title":"Complex landscapes of somatic rearrangement in human breast cancer genomes","volume":"462","author":"Stephens","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0340","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-04-1526","article-title":"CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a\/ARF locus","volume":"65","author":"Hernandez","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0345","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1158\/0008-5472.CAN-08-2739","article-title":"MLL1 mediate oncogene-induced p16INK4a activation","volume":"69","author":"Kotake","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0350","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/S0002-9440(10)65071-7","article-title":"INK4a\/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene","volume":"156","author":"Pinyol","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0355","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1182\/blood-2002-04-1078","article-title":"CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas","volume":"100","author":"Tort","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0360","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/sj.leu.2403571","article-title":"Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms","volume":"19","author":"Tort","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0365","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0370","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jmg.2005.032367","article-title":"Global analysis of uniparental disomy using high density genotyping arrays","volume":"42","author":"Bruce","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0375","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1182\/blood-2008-08-174953","article-title":"Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation","volume":"113","author":"O\u2018shea","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0380","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood-2007-05-088310","article-title":"Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray","volume":"111","author":"Kawamata","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0385","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2141.2008.07199.x","article-title":"Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis","volume":"142","author":"Katzenberger","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0390","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2141.2007.06526.x","article-title":"Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH","volume":"137","author":"Parry-Jones","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0485","doi-asserted-by":"crossref","unstructured":"Halldorsdottir AM, Lundin A, Murray F, Mansouri L, Knuutila S, Sundstrom C, et al. Impact of TP53 mutation and 17p deletion in mantle cell lymphoma. Leukemia 2011. E Publised.","DOI":"10.1038\/leu.2011.162"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0400","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2011.02.002","article-title":"Importance of genetics in chronic lymphocytic leukemia","volume":"25","author":"Zenz","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0405","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.humpath.2005.08.021","article-title":"Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma?","volume":"36","author":"Espinet","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0410","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/S0046-8177(03)00410-6","article-title":"Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes","volume":"34","author":"Nodit","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0415","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","article-title":"p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas","volume":"87","author":"Hernandez","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0420","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302","article-title":"p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis","volume":"87","author":"Greiner","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0425","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1182\/blood.V99.8.3075","article-title":"Mutations of Chk2 in primary hematopoietic neoplasms","volume":"99","author":"Hangaishi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0430","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0435","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0440","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0490","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/leu.2011.114","article-title":"Somatic mutations in acute promyelocytic leukemia (APL) identified by exome sequencing","volume":"25","author":"Greif","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0450","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0495","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0500","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0505","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation","volume":"208","author":"Fabbri","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.semcancer.2011.09.007_bib0470","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/leu.2009.31","article-title":"t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals","volume":"23","author":"Lecluse","year":"2009","journal-title":"Leukemia"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X11000563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X11000563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T23:02:19Z","timestamp":1712876539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X11000563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1044579X11000563"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2011.09.007","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}